Movatterモバイル変換


[0]ホーム

URL:


AU2003221173A1 - Placenta-origin mesenchymal cells and medicinal use thereof - Google Patents

Placenta-origin mesenchymal cells and medicinal use thereof

Info

Publication number
AU2003221173A1
AU2003221173A1AU2003221173AAU2003221173AAU2003221173A1AU 2003221173 A1AU2003221173 A1AU 2003221173A1AU 2003221173 AAU2003221173 AAU 2003221173AAU 2003221173 AAU2003221173 AAU 2003221173AAU 2003221173 A1AU2003221173 A1AU 2003221173A1
Authority
AU
Australia
Prior art keywords
placenta
mesenchymal cells
medicinal use
origin mesenchymal
origin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003221173A
Inventor
Koichi Igura
Tsuneo Takahashi
Nobukazu Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Nipro Corp
Asahi Kasei Medical Co Ltd
Original Assignee
Asahi Medical Co Ltd
Asahi Kasei Corp
Nipro Corp
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Medical Co Ltd, Asahi Kasei Corp, Nipro Corp, Asahi Chemical Industry Co LtdfiledCriticalAsahi Medical Co Ltd
Publication of AU2003221173A1publicationCriticalpatent/AU2003221173A1/en
Abandonedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

AU2003221173A2002-03-272003-03-26Placenta-origin mesenchymal cells and medicinal use thereofAbandonedAU2003221173A1 (en)

Applications Claiming Priority (7)

Application NumberPriority DateFiling DateTitle
JP20020899962002-03-27
JP2002-899962002-03-27
JP2002-2957212002-10-09
JP20022957212002-10-09
JP2003-641122003-03-10
JP20030641122003-03-10
PCT/JP2003/003760WO2003080822A1 (en)2002-03-272003-03-26Placenta-origin mesenchymal cells and medicinal use thereof

Publications (1)

Publication NumberPublication Date
AU2003221173A1true AU2003221173A1 (en)2003-10-08

Family

ID=28457596

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU2003221173AAbandonedAU2003221173A1 (en)2002-03-272003-03-26Placenta-origin mesenchymal cells and medicinal use thereof

Country Status (3)

CountryLink
JP (1)JPWO2003080822A1 (en)
AU (1)AU2003221173A1 (en)
WO (1)WO2003080822A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US9592258B2 (en)2003-06-272017-03-14DePuy Synthes Products, Inc.Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US8790637B2 (en)2003-06-272014-07-29DePuy Synthes Products, LLCRepair and regeneration of ocular tissue using postpartum-derived cells
US9572840B2 (en)2003-06-272017-02-21DePuy Synthes Products, Inc.Regeneration and repair of neural tissue using postpartum-derived cells
US7875272B2 (en)2003-06-272011-01-25Ethicon, IncorporatedTreatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US11191789B2 (en)2003-06-272021-12-07DePuy Synthes Products, Inc.Cartilage and bone repair and regeneration using postpartum-derived cells
GB0329449D0 (en)*2003-12-192004-01-28Omnicyte LtdStem cells
JP4838981B2 (en)*2004-01-262011-12-14直秀 山下 A topical skin preparation containing mesenchymal cells derived from human placenta
US20060069008A1 (en)2004-09-282006-03-30Sanjay MistryTreatment of neurological deficits in the striatum or substanta nigra pars compacta
WO2006071778A2 (en)2004-12-232006-07-06Ethicon IncorporatedTreatment of parkinson's disease and related disorders using postpartum derived cells
EP1971681B1 (en)2005-12-162017-08-23DePuy Synthes Products, Inc.Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US9125906B2 (en)2005-12-282015-09-08DePuy Synthes Products, Inc.Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
WO2007079183A2 (en)*2005-12-292007-07-12Anthrogenesis CorporationPlacental stem cell populations
CN103255098A (en)*2006-10-232013-08-21人类起源公司Methods and compositions for treatment of bone defects with placental cell populations
PT103843B (en)*2007-10-042008-08-12Medinfar Produtos Farmaceutico PRECURSOR CELL ISOLATION METHOD FROM THE HUMAN UMBILICAL CORD
GB0818725D0 (en)2008-10-132008-11-19Habib Nagy APharmaceutical composition
US10179900B2 (en)2008-12-192019-01-15DePuy Synthes Products, Inc.Conditioned media and methods of making a conditioned media
BRPI0923068B1 (en)2008-12-192021-05-25Advanced Technologies And Regenerative Medicine, Llc USE OF CELLS DERIVED FROM UMBILICAL CORD TISSUE TO TREAT A PATIENT HAVING A PULMONARY DISEASE, DISORDER OR INJURY
ES2629003T3 (en)2009-03-262017-08-07DePuy Synthes Products, Inc. Human umbilical cord tissue cells as a treatment for Alzheimer's disease
AR093183A1 (en)2010-12-312015-05-27Anthrogenesis Corp INCREASE IN THE POWER OF PLACENTA MOTHER CELLS USING MODULATING RNA MOLECULES
CN113559126A (en)2011-06-012021-10-29人类起源公司 Treating pain with placental stem cells
RU2636220C2 (en)2011-12-232017-11-21Депуи Синтез Продактс, Инк.Detection of cells obtained from umbilical cord tissue
US20210047612A1 (en)*2018-03-062021-02-18Epibone, Inc.Injectable off-the- shelf cartilage, tendon, and ligament repair compositions and methods of use
CN108324927B (en)*2018-05-042021-08-03上海市内分泌代谢病研究所 Use of osteocalcin in preparing medicine for treating Parkinson's disease
JP7672647B2 (en)2021-02-052025-05-08株式会社カネカ Pharmaceutical composition for soft tissue regeneration containing a cell population including mesenchymal stem cells

Also Published As

Publication numberPublication date
JPWO2003080822A1 (en)2005-07-28
WO2003080822A1 (en)2003-10-02

Similar Documents

PublicationPublication DateTitle
AU2003221173A1 (en)Placenta-origin mesenchymal cells and medicinal use thereof
AU2003217350A1 (en)Proliferated cell lines and uses thereof
AU2003259055A1 (en)Cell and tissue culture device
AU2003281736A1 (en)Electrodes and related devices
AU2003214945A1 (en)Multi-function catheter and use thereof
AU2003272187A1 (en)Novel nanoparticles and use thereof
EP1519431A4 (en)Electrode and cell comprising the same
AU2002225681A1 (en)Yeast-dentritic cell vaccines and uses thereof
AU2001264763A1 (en)Human mesenchymal progenitor cell
AU2002364051A1 (en)Anti-cancer combination and use thereof
AU2003296369A1 (en)Imminoamines and preparation thereof
AU2003218261A1 (en)Improvements in pharmaceutical discovery and development
AU2003281691A1 (en)Furoisoquinoline derivative and use thereof
AU2003207628A1 (en)Structural and cytoskeleton-associated proteins
AU2003231827A1 (en)Pseudo-tissues and uses thereof
AU2003220966A1 (en)Drug containing human placenta-origin mesenchymal cells and process for producing vegf using the cells
AU2003302173A1 (en)Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003280799A1 (en)Medicinal composition
AU2003215767A1 (en)Devices for use in medicine
AU2002306358A1 (en)Charger and communication instrument unit using the charger
AU2003264474A1 (en)Novel uracil derivatives and medicinal use thereof
AU2003240446A1 (en)Use of mob-5 in pain
AU2003220265A1 (en)Tamperproof and counterfeit-resistant structure
AU2003280678A1 (en)Medicinal composition
AU2003228397A1 (en)HAUSP-p53 INTERACTION AND USES THEREOF

Legal Events

DateCodeTitleDescription
MK6Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

[8]ページ先頭

©2009-2025 Movatter.jp